NYSE: CRCrane Co Stock
$201.06+3.27 (+1.65%)
Updated Nov 6, 2026
CR Price
$201.06
Fair Value Price
N/A
Market Cap
$11.63B
52 Week Low
$159.58
52 Week High
$230.50
P/E
33.96x
P/B
5.13x
P/S
4.28x
PEG
2.03x
Dividend Yield
0.5%
Revenue
$2.76B
Earnings
$342.00M
Gross Margin
41.5%
Operating Margin
18.03%
Profit Margin
12.4%
Debt to Equity
0.76
Operating Cash Flow
$427M
Beta
1.26
Next Earnings
N/A
Ex-Dividend
Nov 30, 2026
Next Dividend
Dec 9, 2026
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Industrial Machinery
Industry Rating
B
CR
Ranked#30 of 71
Ranked#30 of 71
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $43.39 | A | |
| $67.76 | A | |
| $22.85 | A |
Be the first to know about important CR news, forecast changes, insider trades & much more!
CR News
Overview
Due Diligence Score
–
Industry Average (38)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CR ($201.06) is trading above its intrinsic value of $58.64, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CR is good value based on its earnings relative to its share price (33.96x), compared to the US market average (39.29x)
P/E vs Market Valuation
CR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CR due diligence checks available for Premium users.
Valuation
CR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
33.96x
Industry
35.9x
Market
39.29x
CR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.13x
Industry
5.03x
CR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CR price to earnings growth (PEG)
For valuing profitable companies with growth potential
CR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CR's financial health
Profit margin
Revenue
$754.6M
Net Income
$97.3M
Profit Margin
12.9%
CR's Earnings (EBIT) of $496.90M... subscribe to Premium to read more.
Interest Coverage Financials
CR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.0B
Liabilities
$1.7B
Debt to equity
0.76
CR's short-term assets ($1.49B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CR's short-term assets ($1.49B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$128.4M
Investing
$19.7M
Financing
-$182.9M
CR's operating cash flow ($427.00M)... subscribe to Premium to read more.
Debt Coverage Financials
CR vs Specialty Industrial Machinery Stocks
Crane Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.